Related Experiment Video
Updated: Nov 2, 2025

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
Published on: October 17, 2025
Current status of intensive end-of-life care in children with hematologic malignancy: a population-based study
Nobuyuki Yotani1, Daisuke Shinjo2, Motohiro Kato3
1Department of Palliative Medicine, National Centre for Child Health and Development, 2-10-1, Okura, Setagaya-ku, Tokyo, Japan. yotani-n@ncchd.go.jp.
Insights
Children with hematologic malignancies receive more intensive end-of-life care (EOLC) than those with solid tumors. Younger age and shorter hospital stays are linked to intensive EOLC in these pediatric patients.
Area of Science:
- Pediatric Oncology
- Palliative Care Research
- Hematologic Malignancies
Background:
- Limited data exist on end-of-life care (EOLC) quality for children with hematologic malignancies.
- Adults with hematologic malignancies receive less palliative care and more intensive treatments near end-of-life compared to solid tumor patients.
Purpose of the Study:
- Compare intensive EOLC between pediatric hematologic malignancy and solid tumor patients.
- Identify factors associated with intensive EOLC in children with hematologic malignancies.
Main Methods:
- Retrospective review of pediatric cancer patients (0-18 years) who died in hospital in Japan (2012-2016).
- Defined intensive EOLC indicators: ICU admission, CPR, ventilation, dialysis, ECMO (last 30 days), or chemotherapy (last 14 days).
- Used regression models to determine factors associated with intensive EOLC.
Main Results:
- Children with hematologic malignancies (36%) received significantly more intensive EOLC (ICU admission, CPR, ventilation, dialysis, ECMO, chemotherapy) than solid tumor patients.
- Over 90% of children with hematologic malignancies received blood transfusions in the last 7 days of life.
- Younger age (<5 years) and shorter hospital stays were associated with intensive EOLC in hematologic malignancy patients.
Conclusions:
- Pediatric patients with hematologic malignancies are more likely to receive intensive end-of-life care compared to those with solid tumors.
- Younger age and shorter hospital stays may be associated with receiving intensive EOLC in children with hematologic malignancies.
Background:
Adult patients with hematologic malignancies are less likely to receive palliative care and more likely to accept intensive anti-cancer treatments until end-of-life than those with solid tumors, but limited data are available regarding the quality of end-of-life care (EOLC) for children with hematologic malignancies. To improve the quality of EOLC for children with hematologic malignancies, the aims of this study were (i) to compare intensive EOLC between children with hematologic malignancies and those with solid tumors; and (ii) to describe factors associated with intensive EOLC in children with hematologic malignancies.
Methods:
We retrospectively reviewed 0- to 18-year-old patients with cancer, who died in hospital between April 2012 and March 2016 in Japan using the Diagnosis Procedure Combination per-diem payment system. Indicators of intensive inpatient EOLC were defined as intensive care unit admission, cardiopulmonary resuscitation (CPR), intubation and/or mechanical ventilation, hemodialysis, or extra-corporeal membrane oxygenation in the last 30 days of life, or intravenous chemotherapy in the last 14 days. We determined factors associated with intensive EOLC using regression models. Data regarding use of blood transfusion were also obtained from the database.
Results:
Among 1199 patients, 433 (36%) had hematological malignancies. Children with hematologic malignancies were significantly more likely than those with solid tumors to have intubation and/or mechanical ventilation (37.9% vs. 23.5%), intensive care unit admission (21.9% vs. 7.2%), CPR (14.5% vs. 7.7%), hemodialysis (13.2% vs. 3.1%) or extra-corporeal membrane oxygenation (2.5% vs. 0.4%) in their last 30 days, or intravenous chemotherapy (47.8% vs. 18.4%; all P < .01) within their last 14 days of life. Over 90% of children with hematological malignancies received a blood transfusion within the last 7 days of life. For hematological malignancies, age under 5 years was associated with CPR and ≥ 2 intensive EOLC indicators. Longer hospital stays had decreased odds of ≥ 2 intensive EOLC indicators.
Conclusion:
Children with hematologic malignancies are more likely to receive intensive EOLC compared to those with solid tumors. A younger age and shorter hospital stay might be associated with intensive EOLC in children with hematologic malignancies.
More Related Videos
09:57Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018
10:49Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
Published on: September 18, 2013
Related Concept Videos
Regulation of Hematopoietic Stem Cells
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Continuing Care
Hematopoiesis